2279 — Yonghe Medical Co Income Statement
0.000.00%
- HK$887.63m
- HK$848.41m
- CNY1.80bn
- 68
- 77
- 71
- 86
Annual income statement for Yonghe Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,638 | 2,169 | 1,413 | 1,777 | 1,804 |
| Cost of Revenue | |||||
| Gross Profit | 1,222 | 1,580 | 873 | 997 | 1,084 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,372 | 1,912 | 1,574 | 2,309 | 1,968 |
| Operating Profit | 266 | 256 | -162 | -532 | -164 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 231 | 210 | -109 | -585 | -255 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 163 | 120 | -85.9 | -547 | -227 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 163 | 120 | -85.9 | -546 | -226 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 163 | 120 | -84 | -538 | -226 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.317 | 0.329 | -0.164 | -0.986 | -0.32 |
| Dividends per Share |